Killer Cell Immunoglobulin-Like Receptor, Two Domains, Short Cytoplasmic Tail, 5

Alternative Names

  • KIR2DS5
  • NK-Associated Transcript 9
  • NkAT9
  • CD158G

Associated Diseases

Myeloma, Multiple
Back to search Result
OMIM Number

604956

NCBI Gene ID

3810

Uniprot ID

Q14953

Length

7,717,617 bases

No. of isoforms

1

Protein Name

Killer cell immunoglobulin-like receptor 2DS5

Molecular Mass

33698 Da

Amino Acid Count

304

Genomic Location

chr19:50,900,000-58,617,616

Gene Map Locus
19q13.4

Description

Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response.

Epidemiology in the Arab World

View Map

Other Reports

Lebanon

No association has been found in the Lebanese population between KIR2DS5 genotypes and various disease conditions, including Non-Hodgkin's Lymphoma (Hoteit et al. 2015), Folicular Lymphoma (Khalaf et al. 2013), Behcet's Diseases (Arayssi et al. 2009), Tuberculosis (Mahfouz et al. 2011), Familial Mediterranean Fever (Mahfouz et al. 2009), and Tonsillitis (Bitar et al. 2008).  However, Hoteit et al. 2014 found  KIR2DS5  to be significantly more prevelent in patients with Multiple Myeloma in this population.

© CAGS 2024. All rights reserved.